Nang Kuang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Nang Kuang Pharmaceutical has a total shareholder equity of NT$2.3B and total debt of NT$508.8M, which brings its debt-to-equity ratio to 21.8%. Its total assets and total liabilities are NT$3.5B and NT$1.2B respectively. Nang Kuang Pharmaceutical's EBIT is NT$205.3M making its interest coverage ratio 576.8. It has cash and short-term investments of NT$229.5M.
Key information
21.8%
Debt to equity ratio
NT$508.75m
Debt
| Interest coverage ratio | 576.8x |
| Cash | NT$229.47m |
| Equity | NT$2.33b |
| Total liabilities | NT$1.21b |
| Total assets | NT$3.54b |
Recent financial health updates
Recent updates
There May Be Some Bright Spots In Nang Kuang Pharmaceutical's (TWSE:1752) Earnings
Nov 19
Nang Kuang Pharmaceutical Co., Ltd.'s (TWSE:1752) 28% Price Boost Is Out Of Tune With Earnings
May 22Some Investors May Be Willing To Look Past Nang Kuang Pharmaceutical's (TWSE:1752) Soft Earnings
Apr 02Nang Kuang Pharmaceutical (GTSM:1752) Has A Pretty Healthy Balance Sheet
Mar 20Should You Or Shouldn't You: A Dividend Analysis on Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)
Mar 03Declining Stock and Decent Financials: Is The Market Wrong About Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)?
Feb 13
Nang Kuang Pharmaceutical's (GTSM:1752) Stock Price Has Reduced 17% In The Past Five Years
Jan 26Estimating The Fair Value Of Nang Kuang Pharmaceutical Co., Ltd. (GTSM:1752)
Jan 08Here's How We Evaluate Nang Kuang Pharmaceutical Co., Ltd.'s (GTSM:1752) Dividend
Nov 29Financial Position Analysis
Short Term Liabilities: 1752's short term assets (NT$1.4B) exceed its short term liabilities (NT$1.1B).
Long Term Liabilities: 1752's short term assets (NT$1.4B) exceed its long term liabilities (NT$91.4M).
Debt to Equity History and Analysis
Debt Level: 1752's net debt to equity ratio (12%) is considered satisfactory.
Reducing Debt: 1752's debt to equity ratio has increased from 21.4% to 21.8% over the past 5 years.
Debt Coverage: 1752's debt is well covered by operating cash flow (85.9%).
Interest Coverage: 1752's interest payments on its debt are well covered by EBIT (576.8x coverage).